Cabozantinib In Combo With NIVO + IPI In Advanced NCCRCC
ACTIVE_NOT_RECRUITING
Status
Conditions
- Papillary Renal Cell Carcinoma
- Unclassified Renal Cell Carcinoma
- Translocation Renal Cell Carcinoma
- Chromophobe Renal Cell Carcinoma
- Collecting Duct Renal Cell Carcinoma
- Renal Cell Carcinoma
- Unresectable Advanced Renal Cell Carcinoma
- Metastatic Ncc Renal Cell Carcinoma
Interventions
- DRUG: Cabozantinib
- DRUG: Nivolumab
- DRUG: Ipilimumab
Sponsor
Bradley A. McGregor, MD
Collaborators
- [object Object]
- [object Object]